The impact of a global pandemic on orthopaedic services: The collaborative approach in a UK major trauma centre
https://www.boa.ac.uk/policy-engag...pact-of-a-global-pandemic-on-orthopaedic.html
All junior doctors, middle-grade registrars and consultants also received departmental fast-track training for the use of conscious sedation techniques including Penthrox (Methyoxyflurane). Penthrox is currently licensed in the UK and indicated for the emergency relief of moderate-to-severe pain in the conscious adult trauma patient. Key advantages of this patient-controlled analgesia include high-quality pain-relief, and a rapid half-life and post-sedation recovery therefore negating prolonged supervised stay within the minor injury unit7–11.
New inhaled analgesic can save hospital time and resources
https://pharmafield.co.uk/pharma_news/new-inhaled-analgesic-can-save-hospital-time-and-resources/
Ann: COVID-19 Impact on MVP, page-28
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.010(2.15%) |
Mkt cap ! $53.51M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 48.0¢ | 46.5¢ | $42.73K | 90.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26916 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 4750 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |